All Cardiovascular articles
-
Working party guideline/algorithmBest practice treatment and management of patients with type 2 diabetes, cardiovascular disease, and heart failure
This management algorithm was developed by a multidisciplinary expert panel: Javaid et al with the support of an educational grant from AstraZeneca. Information intended for UK healthcare professionals.
-
Hosted content
Anticoagulation management for elderly patients with NVAF, CKD and other comorbidities
This promotional webinar was organised and funded by the Bristol Myers Squibb/Pfizer Alliance and is intended for UK healthcare professionals only.
Click HERE to view ELIQUIS (apixaban) prescribing information and adverse events reporting
Adverse events should be reported. Reporting forms and information can be found at: UK – www.mhra.gov.uk/yellowcard, or search for MHRA Yellow Card in the Google Play or Apple App Store Adverse events should also be reported to Bristol-Myers Squibb via medical.information@bms.com or 0800 731 1736 (UK).
432-GB-2200204 May 2022 -
PHE/DH/DWP guideline
NHS statin intolerance pathway
A Guidelines summary covering the definition, classification, and management of statin intolerance
-
NICE guideline
NICE stroke and TIA guideline
This concise summary (updated in April 2022) covers the rapid recognition of symptoms and diagnosis of stroke and transient ischaemic attack
-
NICE guideline
NICE hypertension guideline
Guidance on the diagnosis and management of hypertension, with updated recommendations on blood pressure targets and antihypertensive drug treatment
-
News
Soluble paracetamol linked to increased risk of cardiovascular disease and death
There may be a link between salt-containing dissolvable paracetamol tablets and an increased risk of cardiovascular disease, new research suggests
-
eLearning module
Transitioning eligible patients with NVAF from warfarin to direct oral anticoagulants—a patient case study
This promotional Learning module has been commissioned and funded by Bayer plc and developed in partnership with Guidelines.
View adverse event reporting and prescribing information for Xarelto▼(rivaroxaban)
PP-XAR-GB-2415 January 2022 -
Independent professional body guideline
BLS managing lymphoedema and DVT guideline
Covering symptoms and management of lymphoedema and DVT, including compression use in VTE
-
eLearning module
Management of venous thromboembolism in primary care
This promotional eLearning module has been funded by Bristol Myers Squibb on behalf of the BMS / Pfizer Alliance and developed in conjunction with Guidelines. The promotional content on this page is intended for UK healthcare professionals only.
View ELIQUIS (apixaban) prescribing and adverse event reporting information
432-GB-2100953 | February 2022 -
SIGN guideline
SIGN venous thromboembolism in COVID-19 guideline
A short summary of recommendations on preventing and managing COVID-19-related venous thromboembolism in the community
-
News
Current ‘safe’ alcohol consumption levels potentially harmful
New research suggests that even consuming less than the currently recommended safe level of alcohol is associated with increased cardiovascular risk, with researchers advising a reduction in safe level guidance
-
News
Hidden burden of severe aortic stenosis far exceeds current NHS capacity
A new analysis of the data on severe aortic stenosis reveals that the potential demand from undiagnosed patients exceeds NHS capacity to screen or treat the disease
-
NHS guideline
NHS lipid management pathway
This Guidelines summary covers key recommendations from national guidance on lipid management for the primary and secondary prevention of cardiovascular disease
-
Animation
Changes to the NICE atrial fibrillation (AF) guideline and anticoagulation treatment options—what do they mean to you?
This promotional animation has been commissioned by Bayer plc and developed in partnership with Guidelines.
View Xarelto▼ (rivaroxaban) prescribing information and adverse event reporting
PP-XAR-GB-2154 December 2021 -
NICE guideline
NICE heart valve disease guideline
Covering investigation and management of heart valve disease in adults
-
News
Heart failure could be diagnosed earlier in primary care
New research suggests that three-quarters of patients with heart failure could be identified earlier with increased natriuretic peptide testing in primary care
-
News
NICE publishes updated guidance on the management of acute heart failure
The guideline includes recommendations on diagnosis, assessment and monitoring, initial pharmacological and nonpharmacological treatment, management after stabilisation, and the use of mechanical devices
-
News
NICE publishes guideline on the management of heart valve disease
The new guidance outlines how adults with heart valve disease should be investigated and managed
-
News
Publicly available defibrillators less common in deprived areas
New research shows that publicly accessible AEDs are not located in the areas that need them most
-
News
PSNC offers new resources on Hypertension Case-Finding Service
Community pharmacy can offer the advanced service to identify undiagnosed cases of cardiovascular disease and support general practice in the prevention and management of cardiovascular conditions
